US › Healthcare

Turn Therapeutics Inc. Common Stock (TTRX)

US · Healthcare · Biotechnology

$9.52+7.69%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Net profit
$-970,972
Profit YoY
-175.9%
EPS
$-0.04
EPS estimate
$-0.02

EPS came in at -0.04 against a street estimate of -0.02 — a miss of 100.0%.

Key statistics

Market cap
$263.3M
Forward P/E
0.0
P/B
40.95
Book value
$0.20
EPS (TTM)
$-0.13
52-week high
$11.69
52-week low
$2.57
50-day MA
$7.14
200-day MA
$4.67

Analyst view

with an average price target of $26.00.

Shareholding

Insiders
54.12%
Institutions
2.75%

Largest institutional holders

FundStake
Steel Peak Wealth Management LLC0.84%
DDFG Inc0.24%
Millennium Management LLC0.23%
Wellington Shields & Co., LLC0.22%
Vanguard Capital Management, LLC0.17%
Vanguard Group Inc0.10%
Tamar Securities, LLC0.10%
Brown Brothers Harriman & Co0.08%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Turn Therapeutics Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.